Pfizer Inc.
The Pfizer/BioNTech Covid vaccine, which has an efficacy of almost 95%, has been authorized by the UK medicines regulator, making the UK the first western country to license a vaccine against the disease. The UK has 40m doses of this vaccine on order. The vaccine works by introducing into
Pharmaceutical industry
Health care workers and nursing home residents may be able to receive coronavirus vaccinations as early as December, while the general public may not be able to get vaccinated until late spring or the summer, depending on the availability of vaccines and manufacturing capacity. The CDC estimates that 264 million
Pharmaceutical industry
The UK government has imposed strict Covid-19 restrictions on nearly 99% of England, effective December 2, prompting a furious reaction from Boris Johnson's Conservative Party. The new measures, which ban indoor mixing between households, will affect millions of people across the country. Meanwhile, AstraZeneca's coronavirus vaccine
Vaccines
Global stocks jumped on Tuesday, with the Dow Jones, S&P 500, and Nasdaq futures rising between 0.3% and 1% after President Donald Trump authorized President-elect Joe Biden's presidential transition process. Trump's move, while still a long way from conceding the election, has eased
Vaccines
Growing optimism over the development of a Covid-19 vaccine continues to drive global markets higher, with the Dow Jones Industrial Average recovering to pre-pandemic levels and the Japanese Nikkei Stock Average reaching its highest levels since the early 1990s. The pound and euro have also benefited from the surge, with
Pharmaceutical industry
U.S. President-elect Joe Biden is expected to nominate a slate of career diplomats and foreign policy experts to key posts in his administration, marking a significant shift away from the Trump era's "America First" agenda and nationalist rhetoric. Antony Blinken, 58, is likely to be
Pharmaceutical industry
Billionaire Microsoft co-founder Bill Gates expressed optimism that nearly all COVID-19 vaccines will be effective, citing early data from Pfizer and Moderna, as well as promising reports from AstraZeneca, Johnson & Johnson, and Novavax. Despite this, he warned that the US is likely to see continued high infection rates and
Pharmaceutical industry
The COVID-19 pandemic has sent shockwaves through the pharmaceutical market, overshadowing wider trends and challenges facing industry leaders. Despite the unprecedented speed of vaccine development, major manufacturers like Pfizer and AstraZeneca, the US pharmaceutical market has seen mixed results this fall, with breakthroughs and disappointments for top manufacturers like Gilead
Pharmaceutical industry
The immuno-oncology drugs market is expected to face a decline in 2020 due to the COVID-19 outbreak but is expected to recover and reach $80.11 billion by 2023 at a compound annual growth rate of 11.79%. The market was valued at $59.64 billion in 2019 and is
Pharmaceutical industry
AstraZeneca's Tagrisso (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has been granted Priority Review in the US for the adjuvant treatment of patients with early-stage (IB, II, and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumour resection
Pharmaceutical industry
Nine of the world's top biopharmaceutical companies have come together to assure the public that the COVID-19 vaccines they are developing have undergone rigorous testing and meet safety and efficacy standards set by regulatory bodies. The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline plc, Johnson & Johnson, Merck (MSD), Moderna
Vaccines
Nine top pharmaceutical companies, including AstraZeneca, BioNTech, and Pfizer, have signed a joint pledge to prioritize the safety of vaccinated individuals in the development of a Covid-19 vaccine. This commitment is outlined in a four-point pledge that emphasizes adherence to high scientific and ethical standards during clinical trials and the
